The longevity conversation has a framing problem. For most of its history — in both popular culture and medical research — the goal has been stated as living longer. More years. A higher number at the end. But for most people, that is not actually what they want. What they want is to stay capable, clear-headed, and physically independent for as long as possible — to remain the person they are rather than watching that person gradually recede. That goal has a name: healthspan. And the science increasingly suggests it is both the more meaningful target and the more achievable one.
Defining the Terms: Lifespan, Healthspan, and the Gap Between Them
Lifespan is simple: it is the total number of years between birth and death. It is a clean, unambiguous number that medicine has gotten quite good at extending over the past century, through improvements in sanitation, nutrition, infection control, and acute care. Global average life expectancy has risen by roughly 30 years since the mid-twentieth century — a genuinely remarkable achievement.
Healthspan is more nuanced. It is the period of life spent in reasonably good health — free from the chronic disease, significant disability, and loss of functional independence that characterize the later years for a large and growing portion of the population. A person who lives to 82 but spends their last 12 years managing diabetes, heart failure, mobility limitations, and cognitive decline has a lifespan of 82 and a healthspan of roughly 70. Those final 12 years are not simply fewer in some abstract accounting — they represent a fundamentally different quality of existence, for both the individual and the people who care for them.
The gap between these two numbers has become one of the most cited concerns in aging research. A 2024 study analyzing WHO data from 183 countries found that the average global gap between lifespan and health-adjusted life expectancy was approximately 9.6 years, and that this gap had grown by 13% since 2000 (Garmany et al., 2024, JAMA Network Open). The same study found that the United States had the largest healthspan-lifespan gap of any developed nation, at 12.4 years on average — meaning Americans spend more than a decade of their lives in a state of significant illness or disability. Among American women, the gap reached 13.7 years. These are not statistics about a distant population. They describe the probable trajectory of a majority of people currently alive in this country, unless that trajectory is actively altered.
Why Lifespan Extension Without Healthspan Extension Is Not the Goal
The uncomfortable implication of the healthspan-lifespan gap data is that much of modern medicine’s success at extending lifespan has been achieved by keeping sick people alive longer rather than by keeping people healthy longer. Intensive care, advanced surgical interventions, and sophisticated pharmaceutical management of chronic diseases have meaningfully extended survival. What they have not done, in most cases, is restore the functional health that was lost. The years gained are often years spent in medical management — not years of independent, capable living.
This is not an argument against modern medicine. It is an argument about goals. The goal that most people actually have — and that longevity science is increasingly oriented around — is not a higher number on the mortality table but a longer period of good function before that final decline. Stanford physician James Fries articulated this idea in 1980 as the compression of morbidity hypothesis: the possibility that the period of significant illness and disability could be compressed into a shorter window at the very end of life, rather than expanding across the final decade or two. The science since then has both supported and complicated this view — some interventions compress illness into a shorter period, others simply delay it proportionally without compressing the ratio. But the goal itself, achieving a longer and more vigorous healthy period followed by a briefer decline, has become the organizing principle for most serious longevity research.
What Healthspan Actually Looks Like in Practice
Healthspan is not defined by a single biomarker or a test result. It is a composite of functional capacities that allow a person to live on their own terms. The dimensions most consistently used in research and clinical assessment include physical function — the ability to move freely, maintain strength, and sustain aerobic capacity without significant limitation; cognitive function — memory, processing speed, executive function, and the absence of meaningful cognitive decline; metabolic health — stable blood glucose regulation, healthy lipid profiles, and the absence of the metabolic syndrome that precedes type 2 diabetes and cardiovascular disease; and freedom from the major chronic conditions — cardiovascular disease, cancer, neurodegenerative disease, and autoimmune conditions — that most commonly define the sickspan years.
Crucially, these dimensions do not decline at the same rate in everyone of the same chronological age. As discussed in our article on the science of biological age, the variation in biological aging between individuals of the same chronological age is substantial, and most of the drivers of that variation are modifiable. Healthspan is not primarily a genetic destiny. It is primarily a trajectory shaped by behavior, environment, and the physiological maintenance choices made over decades.
The Cellular Mechanisms That Drive the Healthspan Gap
The diseases that consume most of the sickspan years — cardiovascular disease, type 2 diabetes, dementia, cancer, frailty — are not independent conditions that strike randomly. They share common upstream drivers at the cellular level: chronic low-grade inflammation, accumulated oxidative damage, declining mitochondrial function, cellular senescence, impaired DNA repair, and metabolic dysregulation. These are the hallmarks of biological aging that researchers including David Sinclair, Judith Campisi, and the team that produced the influential hallmarks of aging framework have documented across decades of work.
NAD+ sits at the intersection of several of these drivers. The sirtuin proteins that NAD+ fuels are directly involved in DNA repair, inflammatory regulation, and metabolic maintenance. Mitochondrial function, which declines as NAD+ falls with age, is one of the strongest cellular correlates of physical functional decline. The AMPK and mTOR pathways discussed in our article on longevity pathways regulate the cellular balance between maintenance and damage accumulation that determines how quickly these sickspan-driving processes advance. Supporting these systems through NAD+ precursor supplementation and the lifestyle behaviors that activate the broader maintenance network is not a strategy for living to 120 — it is a strategy for remaining functionally well into the years when decline typically begins, and then declining more briefly and less severely.
What the Evidence Says About Extending Healthspan
The interventions with the strongest direct evidence for extending healthspan — measured through functional outcomes, disease incidence, and quality-of-life markers — are not exotic. Regular physical activity, particularly resistance training combined with aerobic exercise, is the single most evidence-backed healthspan intervention available. It preserves muscle mass, maintains bone density, supports cardiovascular function, promotes neuroplasticity, and activates the AMPK and sirtuin pathways simultaneously. A dietary pattern oriented around adequate protein, fiber, minimally processed foods, and moderate caloric intake is the second pillar. Sleep quality — consistently restorative sleep — is the third. Not smoking and managing chronic stress are the fourth and fifth.
These five factors are responsible for the majority of the variation in healthspan outcomes between individuals. The supplement strategies discussed across this site — NAD+ precursors, resveratrol, spermidine, and others — are additive to this foundation, not a replacement for it. The honest framing is that NMN or NR supplementation, in the context of an otherwise health-supporting lifestyle, may help maintain the cellular machinery that supports good function as you age. In the context of sedentary behavior, poor sleep, and a diet built around ultra-processed food, supplements address none of the primary drivers of healthspan loss.
Why the Healthspan Frame Changes What You Optimize For
One of the most useful things about thinking in terms of healthspan rather than lifespan is that it changes the time horizon of the question. Lifespan — whether you will live to 75 or 85 or 95 — is a number you will not know until it happens, and it is substantially outside your control. Healthspan — whether you are physically capable and cognitively sharp at 70, 75, and 80 — is something you are actively building or eroding right now, through the daily choices that determine the pace of your biological aging.
This reframing also makes the value of the supplements and strategies discussed on this site more legible. The goal is not to take NMN and live forever. It is to support the cellular processes most associated with sustained function — DNA repair, mitochondrial efficiency, metabolic regulation, inflammation control — so that the gradual decline that is inevitable begins later and proceeds more slowly. A few extra years of full physical and cognitive function, maintained to an age when they would otherwise begin to slip, is a concrete and meaningful outcome. It is also, based on the trajectory of the research, an increasingly realistic one.
This article closes the foundational section of Edit Your Age. From here, the natural next step is moving from the why to the what: understanding the specific supplements that have the best evidence for supporting the cellular systems this section has described. The complete NMN guide is a good starting point, as is the beginner’s stack guide for those ready to think about where to begin.
Frequently Asked Questions About Healthspan and Lifespan
How Is Healthspan Measured?
Healthspan does not have a single universally agreed-upon measurement. At the population level, researchers use health-adjusted life expectancy (HALE) — a WHO metric that weights years lived by their quality, discounting years spent with significant disease or disability. At the individual level, healthspan is assessed through a combination of functional measures (grip strength, walking speed, VO2 max), cognitive assessments, metabolic markers (blood glucose, lipid profiles, inflammatory markers), and the absence of major chronic disease diagnoses. No single number captures it, which is part of why it is harder to track than lifespan but also a richer picture of what is actually happening.
Is the Healthspan-Lifespan Gap Getting Better or Worse?
Worse, on current trends. The 2024 WHO-based analysis found the global gap grew by 13% between 2000 and 2019. In the United States specifically, the gap increased from 10.9 years to 12.4 years over the same period, driven primarily by rising rates of chronic non-communicable disease — particularly metabolic conditions, cardiovascular disease, and musculoskeletal disorders. This widening gap is occurring despite, and in some cases because of, continued improvements in acute care and disease survival. Living longer with chronic illness is not the same as living well.
At What Age Does Healthspan Typically Begin to Narrow?
The visible decline in functional capacity that most people associate with aging — reduced strength, slowing cognitive processing, worsening metabolic markers — typically becomes noticeable in the 50s and 60s for most people. But the cellular processes driving that decline begin decades earlier. NAD+ levels start falling in early adulthood. Mitochondrial efficiency begins declining in the 30s and 40s. Epigenetic age begins diverging meaningfully from chronological age in the 40s for many people. This is one of the strongest arguments for beginning health-maintenance strategies before the decline is clinically apparent, rather than after.
Can Supplements Extend Healthspan Even if They Don’t Extend Lifespan?
This is one of the more interesting questions in longevity research, and the theoretical answer is yes. Healthspan and lifespan are related but not identical targets. An intervention that maintained better physical function and metabolic health through the 70s without necessarily changing the age at death would represent a genuine healthspan benefit — compressing the period of decline rather than extending total life. This is actually the more realistic near-term goal for most supplement strategies. Whether NAD+ precursors achieve this in humans is still being established, but the mechanistic case for healthspan benefits is at least as strong as the case for lifespan extension — and arguably more plausible given where the human evidence currently stands.
How Does the Healthspan Goal Differ From Anti-Aging in the Traditional Sense?
Traditional anti-aging in the consumer sense has largely been about appearance — reducing visible signs of aging in skin, hair, and body composition. The healthspan framing is entirely different: it is about maintaining the internal functional systems that allow independent, capable living. These goals sometimes overlap — the same cellular maintenance processes that support metabolic health also affect skin quality, and the lifestyle behaviors that extend healthspan often improve appearance as a byproduct. But the target is fundamentally different. Healthspan science is asking whether you can still hike at 72, think clearly at 78, and manage your own life at 82 — not whether you look younger than your age at 50.